Jordi Serrats

Jordi is a renowned neurobiologist with nearly 20 years of neuroscience research and industry experience. Most recently, Jordi led the neurodevelopmental disorders biotech unit of Takeda and was a major contributor to the design and progression of its novel drug discovery portfolio. Prior to his tenure at Takeda, Jordi made significant contributions to the neuroinflammation unit at Lundbeck. Jordi received his Ph.D. from the University of Barcelona (focus on the serotonergic system) and completed his post-doctoral studies in neuroinflammation at the Salk Institute for Biological Studies under the mentorship of Dr. Paul Sawchenko.